Active Heart, Stroke & Blood Cells, Biochemistry & Physiology

Investigating non-myocyte regulation of mitochondrial function in failing hearts

In plain English

AI plain-English summary

Heart failure leaves the heart’s energy supply running on empty, and a type of immune cell called a macrophage may be the culprit. Mitochondria—the tiny power plants inside heart muscle cells—stop working properly in heart failure, but why has been unclear. Recent work by the researcher shows that macrophages normally act as caretakers for these mitochondria. In heart failure, however, the macrophages are reprogrammed and lose this ability. This project will map exactly how macrophages and their precursor cells change in people with failing hearts, and link those changes to the heart’s energy output. The researcher will use advanced MRI scans to measure heart energy levels in patients, combined with single-cell genetic analysis to profile immune cells from blood and heart tissue. By integrating these data, they will build a detailed map of the interactions between heart muscle, mitochondria, and immune cells in human heart failure. If successful, this work could identify new drug targets for restoring mitochondrial function in the failing heart—a fundamental shift from current treatments that focus on managing symptoms rather than repairing the energy deficit.

View original technical description
Cardiac energetic deficit and mitochondrial dysfunction pervade human heart failure, though the underlying mechanisms remain unclear. Recent research, including my pilot data, reveals the crucial role of heart macrophages as custodians of cardiac mitochondrial health. However, in heart failure, these macrophages undergo reprogramming, compromising their ability to support mitochondria. In this proposed BHF Intermediate Clinical Research Fellowship, I will unravel alterations in heart macrophages and their circulating monocyte precursors in human heart failure, and determine their links to cardiac energetics and function. Employing advanced magnetic resonance and single-cell transcriptomics at the whole heart/body level (Workstream 1) coupled with spatial genomics at the cell-cell level (Workstream 2), I will concurrently profile cardiac macrophages and energetics from macro- to micro-scale, exploiting natural clinical and informatic experiments to maximise rigour. Subsequently, I will computationally integrate these datasets to construct a compendium of cardio-mitochondrial-immune interactions in human heart failure. Through a systems biology lens, I aim to pinpoint new targets for rejuvenating mitochondria in the failing heart.

View the original record at the funder ↗

Researchers

Andrew Lewis (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Myocardial energetics in ischaemia and heart failure – exploring translational potential (renewal years 14-18)
Examining the role of mitochondrial oxidative stress in dilated cardiomyopathy using a novel therapeutic probe
Novel multi-nuclear magnetic resonance spectroscopy approaches for the sensitive and robust assessment of human cardiac energetics
Investigating the role of cardiolipin metabolism in mitochondrial DNA replication and mitochondrial division
Investigations into cell-specific immunometabolite-dependent signaling mechanisms underpinning cardiac–immune crosstalk

Original classification

None

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.